Your session is about to expire
← Back to Search
Behavioural Intervention
Semi-autonomous myoelectric control algorithm for Upper Arm Amputation
N/A
Waitlist Available
Research Sponsored by Point Designs
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1 (1 hour)
Awards & highlights
Study Summary
This trial is comparing the use of a semi-autonomous control algorithm with the standard of care myoelectric system for people with prosthetic hands.
Eligible Conditions
- Upper Arm Amputation
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 1 (1 hour)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1 (1 hour)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Assessment of Capacity for Myoelectric Control (ACMC)
Trial Design
2Treatment groups
Experimental Treatment
Group I: Standard-of-care then Semi-autonomous myoelectric controlExperimental Treatment2 Interventions
The standard of care myoelectric control algorithm will be implemented on a by-pass prosthetic socket with a sensorized TASKA prosthetic hand
The semi-autonomous myoelectric control algorithm will be implemented on a by-pass prosthetic socket with a sensorized TASKA prosthetic hand.
Group II: Semi-autonomous then Standard-of-care myoelectric controlExperimental Treatment2 Interventions
The semi-autonomous myoelectric control algorithm will be implemented on a by-pass prosthetic socket with a sensorized TASKA prosthetic hand.
The standard of care myoelectric control algorithm will be implemented on a by-pass prosthetic socket with a sensorized TASKA prosthetic hand
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Semi-autonomous myoelectric control algorithm
2022
N/A
~20
Standard-of-care myoelectric control algorithm
2022
N/A
~20
Find a Location
Who is running the clinical trial?
Point DesignsLead Sponsor
4 Previous Clinical Trials
36 Total Patients Enrolled
University of Colorado, BoulderOTHER
119 Previous Clinical Trials
29,183 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Semi-autonomous then Standard-of-care myoelectric control
- Group 2: Standard-of-care then Semi-autonomous myoelectric control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any available slots in this experiment for participants?
"The most recent updates on clinicaltrials.gov suggest that this medical trial is not recruiting at present, despite first being posted in January 1st 2023. Nevertheless, there are still a total of twenty other studies actively enrolling patients for participation."
Answered by AI
Who else is applying?
What site did they apply to?
University of Colorado Boulder
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0
Why did patients apply to this trial?
I am a healthy man and hoping to get money to help my family and help science at the same time.
PatientReceived no prior treatments
Share this study with friends
Copy Link
Messenger